The impact of type 2 diabetes on aging: multidimensional approaches to preserve cognitive health
Authors:
Open Access
- 2 September 2025
- journal article
- review article
- Published by Springer Nature in Acta Diabetologica
- Vol. 62 (12) , 2223-2234
Abstract
The growing prevalence of type 2 diabetes (T2D) among older adults represents a major public health concern, given its association with accelerated cognitive decline and increased risk of neurodegenerative diseases. Several diabetes-related mechanisms, including chronic hyperglycaemia, oxidative stress, vascular dysfunction, and insulin resistance in the brain, negatively impact key cognitive domains, including memory and executive functions. These neuropathophysiological alterations are also linked to structural brain changes, contributing to vulnerability to dementia. This narrative review examines both established and emerging strategies aimed at counteracting the cognitive impact of T2D in aging populations. Traditional interventions, especially structured physical activity programs, have consistently demonstrated benefits for global cognitive functioning. In parallel, new pharmacological treatments, such as GLP-1 receptor agonists (e.g., semaglutide), not only improve glycemic control but may also exert neuroprotective effects. Multidomain approaches integrating metabolic management, nutritional optimization, physical exercise, and social engagement, such as those tested in the J-MIND-Diabetes study, have yielded promising outcomes in preserving cognitive functions. We argue that combining pharmacological and behavioral strategies holds significant potential for supporting cognitive health in elderly individuals with T2D. Such multimodal interventions may enhance resilience to cognitive decline, improve quality of life, and promote healthy brain aging in this at-risk population.Keywords
Funding Information
- Scuola Internazionale Superiore di Studi Avanzati - SISSA
This publication has 73 references indexed in Scilit:
- The Impact of GLP-1 Receptor Agonists (GLP-1 RAs) on Mental Health: A Systematic ReviewCurrent Treatment Options in Psychiatry, 2024
- Glycemic Control, Weight Management, Cardiovascular Safety, and Cost-Effectiveness of Semaglutide for Patients with Type 2 Diabetes Mellitus: A Rapid Review and Meta-analysis of Real-World StudiesDiabetes Therapy, 2024
- Alternative role of glucagon-like Peptide-1 receptor agonists in neurodegenerative diseasesEuropean Journal of Pharmacology, 2022
- Insulin action in the brain: cell types, circuits, and diseasesTrends in Neurosciences, 2022
- Costs and where to find them: identifying unit costs for health economic evaluations of diabetes in France, Germany and ItalyThe European Journal of Health Economics, 2020
- Exercise and Type 2 Diabetes2020
- Cognitive dysfunction in diabetes: how to implement emerging guidelinesDiabetologia, 2019
- Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1Cell Metabolism, 2018
- Impact of different training modalities on glycaemic control and blood lipids in patients with type 2 diabetes: a systematic review and network meta-analysisDiabetologia, 2014
- Hypoglycemic Episodes and Risk of Dementia in Older Patients With Type 2 Diabetes MellitusJAMA, 2009